Table 1. Demographic characteristic and vaccination status of employees with COVID-19.
| Asymptomatic screening | Symptomatic/ Post exposure testing* | |||
|---|---|---|---|---|
| N = 414 | N = 406 | |||
| Unvaccinated | Vaccinated | Unvaccinated | Vaccinated | |
| N = 398 | N = 16 | N = 401 | N = 5 | |
| Age (median, range) | 41.5 (18.75–72.26) | 55.74 (25.51–65.62) | 40.39 (18.06–71.53) | 43.33 (28.65 ~ 53.46) |
| Gender | ||||
| Female | 242 (60.8%) | 8 (50%) | 283 (70.57%) | 4 (80%) |
| Male | 156 (39.2%) | 8 (50%) | 118 (29.43%) | 1 (20%) |
| Race | ||||
| Black | 189 (47.73%) | 4 (25%) | 104 (26.53%) | 1 (20%) |
| White | 162 (40.91%) | 12 (75%) | 243 (61.99%) | 3 (60%) |
| Asian | 16 (4.04%) | 0 | 10 (2.55%) | 0 |
| Hispanic | 17 (4.29%) | 0 | 24 (6.12%) | 0 |
| Others | 12 (3.03%) | 0 | 11 (2.81%) | 1 (20%) |
| Days from second vaccine dose (median, range) | NA | 53 (14–94) | NA | 78 (63–92) |
| Type of Vaccine | ||||
| Pfizer-BioNTech | NA | 15 (93.75%) | NA | 5 (100%) |
| Moderna | NA | 1 (6.25%) | NA | 0 |
*Includes testing due to onset of symptoms consistent with COVID-19 or after exposure to someone with COVID-19.